CoChat

Strategies to optimize the brain availability of central nervous system drug candidates

Wager, Travis T, Villalobos, Anabella, Verhoest, Patrick R, Hou, Xinjun, Shaffer, Christopher L · 2011 · Expert Opinion on Drug Discovery
Cited by 52

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Access to the CNS is essential for most neurotherapeutics to elicit their effects. Leveraging design strategies incorporating physicochemical properties, in vitro and in vivo assays to predict and measure brain penetration, and brain delivery approaches may enable the drug discovery community to improve access of drug candidates into the CNS compartment. AREAS COVERED: This article reviews aspects of the most recent molecular design, in vitro and in vivo strategies, and delivery technologies to optimize the unbound brain concentrations (C (b,u)) of CNS molecules. Through this, the article provides insight into recent ideas and concepts in CNS drug molecule design, methods for evaluating CNS drug exposures and alternative approaches to maximize drug access to neurocompartments. EXPERT OPINION: The most pharmacologically relevant measure in assessing a compound's pharmacodynamic response in the CNS is its C (b,u). The utilization of emerging design strategies, together with in vitro and in vivo assays, may enable the design of molecules with optimal C (b,u):C (p,u) (C (p,u), unbound plasma concentration) and appropriate C (b,u,) to elicit a biological response from the neurotherapeutic target. Where drug properties intrinsically render a compound CNS impaired, using novel CNS delivery approaches may result in sufficient C (b,u) to furnish a biological response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/17460441.2011.564158

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 52

Metadata

Authors
Wager, T. T., Villalobos, A., Verhoest, P. R., Hou, X., & Shaffer, C. L.
Venue
Expert Opinion on Drug Discovery
Published
2011-03-22
Volume
6
Issue
4
Pages
371-381
ISSN
  • 1746-0441 (ISSN-L)
  • 1746-045X
OpenAlex
W2054976145
Cited by
52
References
6
FWCI
2.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies to optimize the brain availability of central nervous system drug candidates. https://app.cochat.ai/papers/10.1517/17460441.2011.564158
The paper
Wager, T. T., Villalobos, A., Verhoest, P. R., Hou, X., & Shaffer, C. L. (2011). Strategies to optimize the brain availability of central nervous system drug candidates. Expert Opinion on Drug Discovery. https://doi.org/10.1517/17460441.2011.564158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.